Concepedia

Katie Yang

KY

Statistics

Publications

4

Citations

143

H-Index

4

Active since

2014

Affiliations

Regeneron (United States)(Current)

Katie Yang is an author at Regeneron (United States) specializing in medicine, cell biology, and cancer research.

ORCID

Top concepts

Publications per year

2014–2023

4

Publications

4

ERBB3/HER2 Signaling Promotes Resistance to EGFR Blockade in Head and Neck and Colorectal Cancer Models

Li Zhang, Carla Castanaro, Bo Luan et al. · Molecular Cancer Therapeutics · 2014 · 56 citations

, , +19

A Biparatopic Antibody–Drug Conjugate to Treat MET-Expressing Cancers, Including Those that Are Unresponsive to MET Pathway Blockade

John O. DaSilva, Katie Yang, Oliver Surriga et al. · Molecular Cancer Therapeutics · 2021 · 40 citations · Full text

A Biparatopic Antibody That Modulates MET Trafficking Exhibits Enhanced Efficacy Compared with Parental Antibodies in MET-Driven Tumor Models

John O. DaSilva, Katie Yang, Andrés E. Perez Bay et al. · Clinical Cancer Research · 2019 · 30 citations

A Bispecific METxMET Antibody–Drug Conjugate with Cleavable Linker Is Processed in Recycling and Late Endosomes

Andrés E. Perez Bay, Devon Faulkner, John O. DaSilva et al. · Molecular Cancer Therapeutics · 2023 · 17 citations · Full text

, , +20

1–4 of 4